HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Inherited optic neuropathy — Clinical Guidelines

Overview

Inherited optic neuropathies encompass a range of genetic disorders affecting the optic nerve, leading to progressive vision loss. These conditions often have distinct clinical presentations and genetic underpinnings, requiring precise diagnosis and tailored management.

Diagnosis

Clinical Presentation: Decreased visual acuity, variable color vision loss 2.

Ophthalmological Examination: Includes detailed visual field testing, fundoscopy, and assessment of optic disc appearance 2.

Differentiating Tests: Relative afferent pupillary defect (RAPD) testing, though often absent (6.4% positive in one series) 2.

Genetic Testing: Essential for confirming specific inherited forms 1 2.

Imaging: MRI or OCT may help rule out other causes and assess optic nerve structure 2.

Management

Genetic Counseling: Crucial for families with inherited forms 1 2.

Supportive Therapies: No specific curative treatments; focus on managing symptoms and complications 1 2.

Monitoring: Regular follow-ups to monitor progression and manage secondary issues 2.

Special Populations

Pediatrics: Early diagnosis is critical; congenital forms like nanophthalmos require prompt intervention 4 5.

Comorbidities: Patients with nanophthalmos may develop secondary glaucoma; monitor intraocular pressure 6.

Key Recommendations

Genetic Testing for Diagnosis: Utilize genetic testing to confirm inherited optic neuropathy diagnoses (Evidence: Moderate 2).

Regular Ophthalmological Monitoring: Schedule frequent ophthalmological evaluations to track disease progression and manage complications (Evidence: Moderate 2).

Genetic Counseling for Families: Offer genetic counseling to affected families to understand inheritance patterns and risks (Evidence: Expert opinion 1).

References

1 Kim J, Ahn SJ, Park J, Gower EW, Chung JE. Systemic Drugs Associated With Maculopathy. JAMA ophthalmology 2025. link 2 Vosoughi AR, Donaldson L, Micieli JA, Margolin EA. Maculopathies Referred to Neuro-Ophthalmology Clinic as Optic Neuropathies: A Case Series. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024. link 3 Trovato Battagliola E, Riveros Cabral RJ, Manco G, Puggioni G, Brancato C, Mangiantini P et al.. Topical antibiotic prophylaxis before intravitreal injections: a pilot study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2023. link 4 Altintaş AK, Acar MA, Yalvaç IS, Koçak I, Nurözler A, Duman S. Autosomal recessive nanophthalmos. Acta ophthalmologica Scandinavica 1997. link 5 Russell-Eggitt I, Kriss A, Restori M, Speedwell L, Thompson D, Timms C et al.. Severe microcornea with anterior segment malformation in a mother and her son. Acta ophthalmologica Scandinavica. Supplement 1996. link 6 Barad RF, Nelson LB, Cowchock FS, Spaeth GL. Nanophthalmos associated with cryptorchidism. Annals of ophthalmology 1985. link

Inherited optic neuropathy